PrescribedRX begins TRT with an at-home or local lab test to check testosterone and key biomarkers. After a provider reviews results, a telemedicine consult determines eligibility. If approved, testosterone injections are shipped discreetly to the patient, with ongoing follow-up included in the treatment plan.
The program highlights injectable testosterone (cypionate/enanthate) as the main modality. The monthly subscription pricing begins at $99/month when committing to a 12-month plan. Although shorter-term plans exist, patients should confirm the specific pricing and commitment length at checkout. All costs are self-pay, and health insurance is not accepted.
PrescribedRX notes that treatment is strictly for men with clinically low testosterone confirmed through lab testing and provider evaluation—not for bodybuilding or performance enhancement. Potential side effects include mild skin changes, mood shifts, fluid retention, and possible impacts on fertility.
All therapy is supervised by licensed medical professionals. PrescribedRX also clarifies that it acts as a patient-management and marketing platform for independent providers; all clinical decisions are made by the prescribing clinician, and payment does not guarantee a prescription.
For individuals seeking an at-home, digitally managed TRT solution with lab-based evaluation, licensed-provider oversight, and straightforward pricing, PrescribedRX presents a clear path.
The included lab testing, defined program steps and self-pay transparency make it relatively convenient compared to traditional in-clinic hormone therapy. Having said that, because it’s self-pay and prescriptions depend on clinical eligibility, users should review their budget and medical eligibility before enrolling.
Emilia Baran, M.D., is a physician with a diverse clinical and research background and has contributed to both academic and community health settings. Dr. Baran volunteers at health clinics, works as a fact-checker for HealthDay News, and participates in multiple clinical research projects.